Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Jump to content

Portal:Viruses

From Wikipedia, the free encyclopedia

The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Symptoms of influenza
Symptoms of influenza

Influenza, or flu, is an infectious disease caused by some orthomyxoviruses, that affects birds and some mammals including humans, horses and pigs. Influenza is predominantly transmitted through the air by coughs or sneezes, creating aerosols containing the virus. It can also be transmitted by contact with bird droppings or nasal secretions, or by touching contaminated surfaces. As the virus can be inactivated by soap, frequent hand washing reduces the risk of infection. Around a third of cases show no symptoms. The most common symptoms include fever, runny nose, sore throat, muscle pains, headache, cough and fatigue. Influenza is occasionally associated with nausea and vomiting, particularly in children. Pneumonia is a rare complication which can be life-threatening.

Influenza spreads around the world in seasonal epidemics, resulting in about 3–5 million cases of severe illness annually, and about 250,000–500,000 deaths, mainly in the young, the old and those with other health problems. Annual influenza vaccinations are recommended for those at high risk. Sporadic influenza pandemics have been recorded since at least the 16th century. The Spanish flu pandemic of 1918–20 is estimated to have killed 50–100 million people.

Selected image

Influenza researcher using a level 3 biosafety cabinet

Biosafety level 3 equipment is used for research with viruses such as influenza that can cause serious disease but for which treatment is available. The biosafety cabinet uses HEPA filters to filter viruses out of the air. This researcher is examining reconstructed 1918 pandemic influenza virus, or "Spanish flu".

Credit: CDC (2005)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Diagrammatic cross-section of T2 phage, showing the DNA (blue) and protein (black) components

The Hershey–Chase experiments were conducted by Alfred Hershey and Martha Chase in 1952 using the T2 bacteriophage (pictured), which is composed of DNA wrapped in a protein shell. Hershey and Chase labelled either the phage DNA using radioactive phosphorus-32 or the protein using radioactive sulphur-35. They allowed the radiolabelled phages to infect unlabelled bacteria, and then agitated in a blender and centrifuged to separate material remaining outside the bacterial cells. The majority of the 32P-labelled DNA entered the host bacterial cell, while all the 35S-labelled protein remained outside. Hershey and Chase also showed that the phage DNA is inserted into the bacteria shortly after the virus attaches to its host.

DNA had been known since 1869, but in 1952 many scientists believed that proteins carried the information for inheritance. Proteins appeared more complex, while DNA was thought to be an inert molecule used for phosphorus storage. These experiments built on earlier research on transformation in bacteria and helped to confirm that DNA, not protein, was the genetic material. Hershey shared the 1969 Nobel Prize in Physiology or Medicine for the research.

Selected outbreak

Quarantine notices at the East Birmingham Hospital where the first case was initially treated

The last recorded smallpox death occurred during the 1978 smallpox outbreak in Birmingham, UK. The outbreak resulted from accidental exposure to the Abid strain of Variola major, from a laboratory, headed by Henry Bedson, at the University of Birmingham Medical School – also associated with an outbreak in 1966. Bedson was investigating strains of smallpox known as whitepox, considered a potential threat to the smallpox eradication campaign, then in its final stages.

A medical photographer who worked on the floor above the laboratory showed smallpox symptoms in August and died the following month; one of her contacts was also infected but survived. The government inquiry into the outbreak concluded that she had been infected in late July, possibly via ducting, although the precise route of transmission was subsequently challenged. The inquiry criticised the university's safety procedures. Bedson committed suicide while under quarantine. Radical changes in UK research practices for handling dangerous pathogens followed, and all known stocks of smallpox virus were concentrated in two laboratories.

Selected quotation

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

Diagram of hepatitis D virus

Hepatitis delta virus or hepatitis D virus (HDV) is a small virusoid, the sole member of the Deltavirus genus. It infects humans. A subviral satellite, it can only replicate in the presence of a hepatitis B (HBV) helper virus. The spherical virion is 36 nm in diameter, with an envelope containing three HBV proteins. The single-stranded, negative-sense, circular RNA genome of 1679 nucleotides is smaller than that of any known animal virus. It has an unusual base composition for an entity that infects animals, and is extensively bound to itself to form a partially double-stranded, rod-shaped structure. These features have led to suggestions that HDV might be related to viroids, small unencapsidated circular RNAs that infect plants. Unlike viroids, HDV encodes a protein, hepatitis D antigen.

Both HDV and HBV enter liver cells using the sodium/bile acid cotransporter as their receptor. They are mainly transmitted via injecting drug use and blood products. More than 15 million people are infected with both viruses, which is associated with a greater risk of liver complications than HBV infection alone. Around one in five jointly infected patients die. The HBV vaccine protects against HDV.

Did you know?

Harald zur Hausen, photographed by Armin Kübelbeck
Harald zur Hausen, photographed by Armin Kübelbeck

Selected biography

Egyptian pharaoh Siptah might be the earliest person whose name is known to have survived polio

Many well-known people have survived the paralytic disease polio. The earliest identified case might be Siptah (pictured), Egyptian pharaoh 1197–1191 BC, whose mummified remains have a deformed leg possibly from polio. Claudius, Roman emperor 41–54 AD, walked with a limp after a childhood disease that historians have hypothesised might have been polio. Novelist Sir Walter Scott suffered paralysis in one leg after a teething fever in 1773, which left him lame; his detailed account of his disease has allowed a retrospective diagnosis of polio to be made with confidence.

For many of those who survived it, paralytic polio was a life-changing experience. The disease can lead to permanent physical disability; Itzhak Perlman, for example, plays the violin seated. Others recover completely, with some going on to excel in sports; Ray Ewry became world's foremost standing jumper after childhood polio. Some survivors, including singer Ian Dury and actress Mia Farrow, have campaigned for polio eradication or for disability rights.

In this month

Electron micrograph of SARS coronaviruses

7 November 1991: Magic Johnson announced his retirement from basketball because of his infection with HIV

14 November 1957: Kuru, the first human prion disease, described by Daniel Gajdusek and Vincent Zigas

16 November 2002: The first case of severe acute respiratory syndrome (virus pictured) recorded in Guangdong, China

17 November 1995: Lamivudine approved for treatment of HIV

22 November 2013: Simeprevir approved for treatment of chronic hepatitis C virus infection

23 November 1978: Structure of tomato bushy stunt virus solved by Stephen Harrison and colleagues, the first atomic-level structure of a virus

24 November 2007: Outbreak of new Ebola species, Bundibugyo virus

26 November 1898: Martinus Beijerinck coined the term contagium vivum fluidum to describe the agent causing tobacco mosaic disease

Selected intervention

Ball-and-stick model of zidovudine
Ball-and-stick model of zidovudine

Zidovudine (ZDV) (also known as AZT and sold as Retrovir) is an antiretroviral drug used in the prevention and treatment of HIV/AIDS. Classed as a nucleoside analogue reverse-transcriptase inhibitor, it inhibits HIV's reverse transcriptase enzyme, which copies the viral RNA into DNA and is essential for its replication. The first breakthrough in AIDS therapy, ZDV was licensed in 1987. While it significantly reduces HIV replication, leading to some clinical and immunological benefits, when used alone ZDV does not completely stop replication, allowing the virus to become resistant to it. The drug is therefore used together with other anti-HIV drugs in combination therapy called highly active antiretroviral therapy. To simplify its administration, ZDV is included in combination pills with lamivudine (Combivir) and lamivudine plus abacavir (Trizivir). ZDV continues to be used to prevent HIV transmission from mother to child during childbirth; it was previously part of the standard post-exposure prophylaxis after needlestick injury.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: